Journal of pain and symptom management
-
J Pain Symptom Manage · May 2024
National Palliative Care Strategy in a conflict affected country: a Jordanian demonstration project.
Palliative care (PC) integration is vital, as endorsed by the World Health Organization. Yet, Jordan, a Middle Eastern country with limited resources, faces ongoing challenges despite efforts to improve palliative and home care. Establishing a national PC strategic framework, with government and stakeholder consensus, is essential for ensuring universal access to high-quality palliative care. However, processes for achieving this, particularly in the Middle East, are underreported. ⋯ Jordan's collaborative development of the inaugural National Palliative and Home Care Strategic Framework, endorsed by the government and stakeholders, provides a comprehensive roadmap for PC advancement. While it promises improved services, effective solutions to workforce and opioid access issues are crucial for successful implementation.
-
J Pain Symptom Manage · May 2024
Observational StudyComparison of pharmacological treatments for agitated delirium in the last days of life.
Antipsychotics are often used in managing symptoms of terminal delirium, but evidence is limited. ⋯ Haloperidol with as-needed benzodiazepine, chlorpromazine, or levomepromazine may be effective and safe for terminal agitation. Chlorpromazine and levomepromazine may have an advantage of no need to change medications.
-
J Pain Symptom Manage · May 2024
Feasibility of a Two-Step Palliative Screening Utilizing Existing Emergency Department Resources.
Although the Emergency Department (ED) offers a unique setting to provide early palliative care, staffing limitations curtail hospitals from establishing ED-palliative partnerships. ⋯ Our project demonstrated feasibility of a two-step ED-palliative protocol by increasing palliative care consultation without necessitating additional staff.
-
J Pain Symptom Manage · May 2024
Dyspnea-related dimensions and self-efficacy: Associations with well-being in advanced lung cancer.
Dyspnea is a complex, multidimensional symptom comprising sensory-perceptual, affective, and functional domains that commonly persists in patients with lung cancer and impairs mental health and quality of life (QOL). However, data are lacking on how dyspnea's dimensions or self-efficacy to manage dyspnea are associated with patient outcomes. ⋯ Dyspnea-related sensory-perceptual experience and self-efficacy were associated with mental health and QOL outcomes in patients with lung cancer. Examining the individual contributions of dyspnea's multiple dimensions provides a nuanced understanding of its patient impact.